19 result(s) for 'Lung'
1 - 10 of 19 results for 'Lung'
Sort by
Show
In this webinar, Dr. Keith Wharton reviews a set of published studies using single cell analysis of lung tissues that have provided ground breaking insight into lung development and disease.
The content of this webinar will encompass detailed technical descriptions of novel and state of the art methods to decalcify tissue samples that will be embedded in paraffin or for frozen sectioning for molecular and nucleic acid analysis for basic research...
Different types of cancers frequently metastase to bone tissue. Treatment planning decisions are often based upon histology and special staining of these distant sites of disease. These decisions may rely on the outcome of immunohistochemistry, in situ...
The potential for non-invasive tests that provide equivalent research and diagnostic value as can be obtained from tissue biopsies is real, but not yet realized. Tissue biopsies allow for identification, phenotyping and molecular analysis of cancer and...
Dr. Farah K. Khalil is the Director of Histology and Immunohistochemistry at Moffitt Cancer Center Laboratory, Tampa, Florida. She is also an Associate Professor with the College of Medicine at the University of South Florida, Department of Pathology & Cell Biology and Oncologic Sciences, in Tampa, Florida. Dr. Khalil did her residency and fellowship at the University of South Florida and has been an active member at the university. She is passionate about lung cancer and active participant in studies and authorships. Her latest peer review article in 2015 is ‘Annotation of human cancers with EGFR signaling associated protein complexes using proximity ligation assays’. Sci. Signal. 8 (359), ra4.doi:10.1126/scisignal.2005906, January 2015. 2013/2014 Journal Impact Factor 6.3...
Dr. Jan von der Thüsen is a histopathologist with subspecialist interests in thoracic and cardiovascular pathology. Thüsen received his medical training at the Universities of Cambridge (UK, Trinity College) and London (UK, Imperial College), and his specialist training at Leiden University Medical Centre (The Netherlands). His Ph.D. was also awarded by Leiden University for research into gene therapeutic approaches to atherosclerosis. He developed his subspecialist interest in thoracic pathology during appointments as consultant histopathologist and university lecturer at the Academic Medical Centre in Amsterdam (The Netherlands), and the Royal Brompton & Harefield NHS Foundation Trust in London. Thüsen currently works as the lead thoracic pathologist at the Erasmus Medica...
In this session, we will briefly review the basics of molecular biology, examine critical factors which affect the quality of nucleic acids in the tissues and cells which are submitted for downstream molecular diagnostics, and briefly introduce some...
In surgical pathology more than ever, the laboratories are expected to do more with less. Taking on more specimens with less technical staff, or getting more stains out of tiny biopsies or fine needle aspirations have become the norm. The College of American...
Dr. Steve A. Kargas is the current Director, Surgical Pathology at CSI Laboratories, Atlanta, GA. He received his medical degree and post doctorate at University of Wisconsin-Madison and his AP residency at Stanford and CP residency at Cedars Sinai Medical Center, LA., CA. Dr. Kargas is highly involved in improving specializing in evaluation, diagnostic immunohistochemical analysis and molecular testing of solid tumors including carcinomas of unknown primary site, soft tissue, colon, prostate, breast, prognostic/diagnostic cases, MMRP, MSI PCR testing, hepatocellular carcinoma, lung including small cell carcinoma vs. non-small carcinoma, and providing solutions to anatomic pathology needs of clients. He is a member of CAP, USCAP, ASCP, ASQ, and ASC.
Routine (or H&E) and special stains allow us to visualize otherwise transparent tissue under a microscope and are critical for tissue-based diagnosis.